DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Plaque Psoriasis
Interventions
DRUG

DFD01 Spray

DRUG

Comp01 Lotion

Trial Locations (12)

19101

Paddington Testing Company, Inc., Philadelphia

27262

Dermatology Consulting Services, High Point

37215

Tennessee Clinical Research Center, Nashville

77004

Center for Clinical Studies, LTD. LLP, Houston

77030

The University of Texas Health Science Center at Houston, Houston

77494

Suzanne Bruce and Associates, PA The Center for Skin Research Katy/Cinco Ranch, Katy

78759

DermResearch, Inc., Austin

87106

Academic Dermatology Associates, Albuquerque

89074

Bettencourt Skin Center, Henderson

91436

Encino Research Center T. Joseph Raoof MD, Inc., Encino

92024

California Dermatology and Clinical Research Institute, Encinitas

95403

Redwood Dermatology Research, Santa Rosa

Sponsors
All Listed Sponsors
collaborator

Prosoft Clinical

OTHER

lead

Primus Pharmaceuticals

INDUSTRY